Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus)

International Journal of Experimental Pathology

Volumn 94, Issue 2, 2013, Pages 156-168

  Smither, Sophie J ^a   Nelson, Michelle ^a   Eastaugh, Lin ^a   Laws, Thomas R ^a   Taylor, Christopher ^a   Smith, Simon A ^a   Salguero, Francisco J ^b   Lever, Mark S ^a  

^a Department of Biomedical Sciences ^*  (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD CLOT; CALLITRICHINAE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEVER; HEPATITIS; HISTOPATHOLOGY; LIVER; LIVER FUNCTION TEST; MALE; MARBURG HEMORRHAGIC FEVER; MARBURG VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RASH; SPLEEN;

ANIMALS; CALLITHRIX; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INHALATION EXPOSURE; KIDNEY; LIVER; LUNG; MALE; MARBURG VIRUS DISEASE; MARBURGVIRUS; MONKEY DISEASES; SPLEEN;

EID: 84875055358     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12018     Document Type: Article

References (59)

1. Adams A.P., Aronson J.F., Tardif S.D. et al. (2008) Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains. J. Virol. 82, 9035-9042.
2. Alves D.A., Glynn A.R., Steele K.E. et al. (2010) Aerosol exposure to the angola strain of Marburg virus causes lethal viral hemorrhagic Fever in cynomolgus macaques. Vet. Pathol. 47, 831-851.
3. Autissier P., Soulas C., Burdo T.H., Williams K.C. (2010) Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry A. 77, 410-419.
4. Bancroft J.D. & Gamble M. (2008) Theory and Practice of histological techniques, 6th edn. Elsevier Health Sciences: Churchill Livingston Elsevier.
5. Baskerville A., Bowen E.T., Platt G.S., McArdell L.B., Simpson D.I. (1978) The pathology of experimental Ebola virus infection in monkeys. J Pathol. 125, 131-138.
6. Baskerville A., Fisher-Hoch S.P., Neild G.H., Dowsett A.B. (1985) Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection. J Pathol. 147, 199-209.
7. Basler C. & Amarasinghe G. (2009) Evasion of the interferon response by Ebola and Marburg viruses. J. Interferon Cytokine Res. 29, 511-520.
8. Bausch D.G., Sprecher A.G., Jeffs B., Boumandouki P. (2008) Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Antiviral Res. 78, 150-161.
9. Bente D., Gren J., Strong J.E., Feldmann H. (2009) Disease modeling for Ebola and Marburg viruses. Dis. Model Mech. 2, 12-17.
10. Borio L., Inglesby T., Peters C.J. et al. Working Group on Civilian Biodefense. 2002. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA. 287: 2391-2405.
11. Bowen E.T., Platt G.S., Simpson D.I., McArdell L.B., Raymond R.T. (1978) Ebola haemorrhagic fever: experimental infection of monkeys. Trans. R. Soc. Trop. Med. Hyg. 72, 188-191.
12. Bray M. (2001) The role of the Type I interferon response in the resistance of mice to filovirus infection. J. Gen. Virol. 82, 1365-1373.
13. Bray M. (2003) Defense against filoviruses used as biological weapons. Antiviral Res. 57, 53-60.
14. Bray M., Davis K., Geisbert T., Schmaljohn C., Huggins J. (1998) A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. 178, 651-661.
15. Bray M., Hatfill S., Hensley L., Huggins J.W. (2001) Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J. Comp. Pathol. 125, 243-253.
16. Carrion R. Jr, Brasky K., Mansfield K. et al. (2007) Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J. Virol. 81, 6482-6490.
17. Carrion Jr R., Ro Y., Hoosien K. et al. (2012) A small non-human primate model for filovirus disease. Virology 420, 117-124.
18. Center for Disease Control List of Bioterrorism Agents (2010). CDC website. Available at: http://www.bt.cdc.gov/agent/agentlist-category.asp (Accessed 23 October 2010).
19. Colebunders R., Tshomba A., Van Kerkhove M.D. et al., International Scientific and Technical Committee "DRC Watsa/Durba 1999 Marburg Outbreak Investigation Group". (2007) Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment. J. Infect. Dis. 196: S148-S153.
20. Daddario-DiCaprio K.M., Geisbert T.W., Ströher U. et al. (2006) Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet 367, 1399-1404.
21. Druett H.A. (1969) A mobile form of the Henderson apparatus. J. Hyg. 67, 437-448.
22. Feldmann H. & Geisbert T.W. (2011) Ebola haemorrhagic fever. Lancet 377, 849-862.
23. Fisher-Hoch S.P., Platt G.S., Lloyd G., Simpson D.I., Neild G.H., Barrett A.J. (1983) Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management. Lancet 2, 1055-1058.
24. Fisher-Hoch S.P., Platt G.S., Neild G.H. et al. (1985) Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J. Infect. Dis. 152, 887-894.
25. Fritz E.A., Geisbert J.B., Geisbert T.W., Hensley L.E., Reed D.S. (2008) Cellular immune response to Marburg virus infection in cynomolgus macaques. Viral Immunol. 21, 355-363.
26. Geisbert T.W. & Jaax N.K. (1998) Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy. Ultrastruct. Pathol. 22, 3-17.
27. Geisbert T.W., Hensley L.E., Larsen T. et al. (2003) Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol. 163, 2347-2370.
28. Geisbert T.W., Daddario-DiCaprio K.M., Geisbert J.B. et al. (2007) Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J. Infect. Dis. 196, S372-S381.
29. Geisbert T.W., Hensley L.E., Geisbert J.B. et al. (2010) Postexposure treatment of Marburg virus infection. Emerg. Infect. Dis. 16, 1119-1122.
30. Gibb T.R., Bray M., Geisbert T.W. et al. (2001) Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J. Comp. Pathol. 125, 233-242.
31. Haas R., Maass G., Oehlert W. (1969) Disease in laboratory personnel associated with vervet monkeys. 3. Experimental infections of monkeys. Primates Med. 3, 138-139.
32. Hartman A.L., Towner J.S., Nichol S.T. (2010) Ebola and Marburg hemorrhagic fever. Clin. Lab. Med. 30, 161-177.
33. Hennessen W. (1971) Epidemiology of "Marburg Virus" disease. In: Marburg Virus Disease, pp. 161-165 (eds. G.A. Martini, R. Siegert ), Berlin, Germany: Springer-Verlag.
34. ICTV (International Committee on Taxonomy of Viruses). (2009) Release. Available at: http://www.ictvonline.org/virusTaxonomy.asp?version=2009 (Accessed March 2011).
35. Jaax N.K., Davis K.J., Geisbert T.J. et al. (1996) Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch. Pathol. Lab. Med. 120, 140-155.
36. Jahrling P.B., Geisbert T.W., Jaax N.K., Hanes M.A., Ksiazek T.G., Peters C.J. (1996) Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. Arch. Virol. 11, 115-134.
37. Johnson E., Jaax N., White J., Jahrling P. (1995) Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int. J. Exp. Pathol. 76, 227-236.
38. Kuhn J.H. (2008) In filoviruses: a compendium of 40 years of epidemiological, clinical, and laboratory studies. In: Filoviruses, p. 101 (ed. C.H. Calisher ). Wien, New York: Springer.
39. Leffel E.K. & Reed D.S. (2004) Marburg and Ebola viruses as aerosol threats. Biosec. Bioterror. 2, 186-190.
40. Lendrum A.C., Fraser D.S., Slidders W., Henderson R. (1962) Studies on the character and staining of fibrin. J. Clin. Pathol. 15, 401.
41. Lever M.S., Howells J.L., Bennett A.M., Parks S., Broster M.G. (2008a) The microbiological validation of a new containment level 4 cabinet line. J. Appl. Biosafety. 13, 98-105.
42. Lever M.S., Stagg A.J., Nelson M. et al. (2008b) Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus). Int. J. Exp. Pathol. 89, 171-179.
43. Lever M.S., Piercy T.J., Steward J.A. et al. (2012) Lethality and pathogenesis of airborne infection with filoviruses in A129 alpha}/{beta -/- interferon receptor-deficient mice. J. Med. Microbiol. 61, 8-15.
44. Lub M., Sergeev A.N., P'Iankova O.V., P'Iankova O.G., Petrishchenko V.A., Kotliarov L.A. (1995) Certain pathogenic characteristics of a disease in monkeys infected with the Marburg virus by an airborne route. Vopr. Virusol. 40, 158-161.
45. Martini G.A. (1973) Marburg virus disease. Postgrad. Med. J. 49, 542-546.
46. Nelson M., Lever M.S., Savage V.L. et al. (2009) Establishment of lethal inhalational infection with Francisella tularensis (tularaemia) in the common marmoset (Callithrix jacchus). Int. J. Exp. Pathol. 90, 109-118.
47. Nelson M., Dean R.E., Salguero F.J. et al. (2011) Development of an acute model of inhalational melioidosis in the common marmoset (Callithrix jacchus). Int. J. Exp. Pathol. 92, 428-435.
48. Orsi A., Rees D., Andreini I., Venturella S., Cinelli S., Oberto G. (2011) Overview of the marmoset as a model in nonclinical development of pharmaceutical products. Regul. Toxicol. Pharmacol. 59, 19-27.
49. Piercy T.J., Smither S.J., Steward J.A., Eastaugh L., Lever M.S. (2010) The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J. Appl. Micobiol. 109, 1531-1539.
50. Reed D.S. & Mohamadzadeh M. (2007) Status and challenges of filovirus vaccines. Vaccine 25, 1923-1934.
51. Reed L.J. & Muench H. (1938) A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493-497.
52. Reed D.S., Lackemeyer M.G., Garza N.L., Sullivan L.J., Nichols D.K. (2011) Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: difference in disease course and clinical pathology. Microbes Infect. 13, 930-936.
53. Rippey J.J., Schepers N.J., Gear J.H. (1984) The pathology of Marburg virus disease. S. Afr. Med. J. 66, 50-54.
54. Rollin P.E., Bausch D.G., Sanchez A. (2007) Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J. Infect. Dis. 196, S364-S371.
55. Salguero F.J., Sanchez-Cordon P.J., Nunez A., Fernandez de Marco M., Gomez-Villamandos J.C. (2005) Proinflammatory cytokines induce lymphocyte apoptosis in acute African swine fever infection. J. Comp. Pathol. 132, 289-302.
56. Schou S., Hansen A.K. (2000) Marburg and Ebola virus infections in laboratory non-human primates: a literature review. Comp. Med. 50:108-123. Review.
57. Shurtleff A.C., Warren T.K., Bavari S. (2011) Nonhuman primates as models for the discovery and development of ebolavirus therapeutics. Expert Opin. Drug Discov. 6, 233-250.
58. Warfield K.L., Alves D.A., Bradfute S.B. et al. (2007) Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virol. J. 4, 108.
59. Warfield K.L., Bradfute S.B., Wells J. et al. (2009) Development and characterization of a mouse model for Marburg hemorrhagic fever. J. Virol. 83, 6404-6415.